CytomX Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-119.0M | $-120.6M | $1.6M | $13.2M |
| FY2022 | $-110.8M | $-112.5M | $1.7M | $13.1M |
| FY2023 | $-56.0M | $-56.9M | $840.0K | $8.6M |
| FY2024 | $-86.2M | $-86.5M | $310.0K | $7.7M |
| FY2025 | $-75.6M | $-75.8M | $220.0K | $6.3M |